Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results

Click here to go back to your search results.

Melanoma treatment details. Chemotherapy. University of Tubingen, Tubingen, Germany

Survival: 9.7 months
Toxicity Grade: 4
Treatments: Chemotherapy
Drugs: Temodar
Country: Germany
City/State/Province: Tubingen
Hospital: University of Tubingen
Journal: Link
Date: 10/2005

Patients: This Phase III study involved a total of 271 patients with metastatic melanoma who were divided into two groups: Group A of 137 patients and Group B of 134 patients. For Group B the median age was 58.

Treatment: The treatment for Group A consisted of one chemotherapy agent (Temozolomide).

Toxicity: Grade 4 toxicities for this group included: hematologic, and nausea.

Results: The median overall survival was 9.7 months.

Support: One author had acted as a consultnat for Schering Plough. This company markets interferon-alpha-2b.

Correspondence: Konstanze Spieth, MD

E-mail to a Friend Email Physician More Information